Why are patients stopping and restarting GLP-1 meds
Mounjaro, differing in its approach, utilizes tirzepatide as its active ingredient, targeting both GLP-1 and GIP receptors, which may, in some cases, enable more significant weight loss compared to Semaglutide GLP-1-based treatments
Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing
Peptides vs Proteins and Hormones Its easy to get peptides, proteins, and hormones mixed up, but their differences are what make them unique tools in medicine
Development Note: Cagrilintide is currently in Phase 3 clinical trials (REDEFINE program) and has not yet received regulatory approval
Two conserved antigenic targets of interest for vaccinologists are the membrane-proximal stalk domain of HA [114] and the ectodomain of the ion channel M2 [115]
